Psychiatry and Neurology, Neurology · Farmington Hills, MI
NPI
1861462129
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
28595 Orchard Lake Rd, Suite 200
Farmington Hills, MI, 48334
Phone (248) 553-0010
Groups this clinician bills Medicare through
Medicare paid, 2024
$6.3M
464,524 services
Medicare patients, 2024
730
Average age 66
Drug cost, 2024
$6.1M
6,491 prescriptions
Company payments, 2025
$101K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Martin I Belkin was code J0174 (injection, lecanemab-irmb, 1 mg), 264,630 times for 26 patients. In total Martin I Belkin billed 464,524 services in 57 codes, and Medicare paid $6.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 264,630 | 26 | $1.05 | $277K |
| J2323 Injection, natalizumab, 1 mg | Office | 59,100 | 30 | $17.68 | $1.0M |
| J2350 Injection, ocrelizumab, 1 mg | Office | 55,500 | 59 | $43.28 | $2.4M |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 25,900 | 17 | $38.58 | $999K |
| J3032 Injection, eptinezumab-jjmr, 1 mg | Office | 22,200 | 33 | $14.24 | $316K |
| J2329 Injection, ublituximab-xiiy, 1mg | Office | 10,650 | 13 | $54.04 | $576K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 6,224 | 89 | $0.22 | $1,361 |
| 96365 Intravenous Infusion, Hydration | Office | 994 | 192 | $47.20 | $47K |
| 99214 Office E&M - Established | Office | 597 | 366 | $83.51 | $50K |
| 96375 Injection Administration | Office | 570 | 112 | $11.03 | $6,289 |
| 96366 Intravenous Infusion, Hydration | Office | 487 | 89 | $15.28 | $7,440 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 230 | 95 | $0.59 | $136 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 128 | 18 | $0.42 | $53.31 |
| 99204 Office E&M - New | Office | 117 | 117 | $120.74 | $14K |
| 99232 Hospital E&M - Subsequent | Facility | 111 | 77 | $62.52 | $6,940 |
By year: 2022 $4.7M for 172,943 services; 2023 $5.2M for 187,794 services; 2024 $6.3M for 464,524 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 15 | 14 | $3.18 | $47.74 |
Medicare prescription drug claims, 2024
In 2024, the drug Martin I Belkin prescribed most often to Medicare patients was Gabapentin, with 346 prescriptions and refills. In total Martin I Belkin wrote 6,491 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 346 | 634 | 93 | $7,678 |
| Baclofen Generic | 293 | 649 | 88 | $6,950 |
| Levetiracetam Generic | 240 | 395 | 46 | $10K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 229 | 249 | 37 | $4,969 |
| Dalfampridine Er Dalfampridine | 192 | 244 | 28 | $95K |
| Clonazepam Generic | 185 | 215 | 26 | $1,745 |
| Alprazolam Generic | 173 | 191 | 34 | $1,425 |
| Pregabalin Generic | 143 | 224 | 29 | $4,136 |
| Zonisamide Generic | 142 | 188 | 17 | $4,699 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 134 | 134 | 25 | $2,503 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 130 | 168 | 29 | $5,565 |
| Duloxetine Hcl Generic | 117 | 212 | 24 | $3,383 |
| Sertraline Hcl Generic | 111 | 258 | 26 | $1,248 |
| Avonex (4 Pack) Interferon Beta-1a | 109 | 109 | 11 | $868K |
| Lacosamide Generic | 107 | 155 | 13 | $17K |
Brand drugs: 982 claims; generic drugs: 5,417 claims; opioid claims: 263.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Martin I Belkin $101K ($101K in general payments such as food, travel and fees) from 14 companies. The largest payer was EMD Serono, Inc. with $34K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 16 | $34K |
| Biogen, Inc. BIIB | 12 | $14K |
| TG Therapeutics, Inc. TGTX | 15 | $14K |
| Amgen Inc. AMGN | 8 | $11K |
| Argenx US, Inc. ARGX | 4 | $7,188 |
| Genentech USA, Inc. ROG.SW | 4 | $6,590 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $5,900 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $4,446 |
| Genzyme Corporation SNY | 1 | $3,295 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $336 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.